Trials / Completed
CompletedNCT02171247
Comparison of Isovue 370 vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)
Comparison of the Use of High Iodine Concentration Contrast Material (Isovue 370) vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Computed Tomography Angiogram (CTA) scans are performed routinely to look at the vessels in the body as an alternative to directly injecting contrast into the vessels and taking pictures. Different types of intravenous (into the vein, IV) contrast are available to fill the vessels and make them easier to see. The purpose of the study is to determine the best type of contrast for this scan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Isovue 370 | Isovue 370 is a contrast agent with increased iodine concentration. |
| DRUG | Visipaque 320 | Visipaque 320 is standard protocol. |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2014-06-24
- Last updated
- 2014-08-15
- Results posted
- 2014-08-15
Source: ClinicalTrials.gov record NCT02171247. Inclusion in this directory is not an endorsement.